von Willebrand Diseases: all 96 studies
Page 1 of 1. Open to participants first (25), then studies with results posted, then the rest; newest registration first within each.
- A Phase II Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of SR604 Injection in Patients With Von Willebrand DiseaseRecruitingNCT07640893Phase 2
- HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMBRecruitingNCT07575308Phase 2
- External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform AnalysisRecruitingNCT07418099
- Clinical Spectrum and Management of Von Willebrand Disease Among Children in Assiut GovernorateNot yet recruitingNCT07410130
- An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)RecruitingNCT07404644
- Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy SubjectsRecruitingNCT07358013
- Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand DiseaseRecruitingNCT07273721Phase 2
- A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)RecruitingNCT07129343Phase 3
- Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)RecruitingNCT07115004Phase 3
- ATHNdataset RegistryRecruitingNCT06820515
- A Study Assessing HMB-002 in Participants With Von Willebrand DiseaseRecruitingNCT06754852Phase 1/2
- Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand DiseaseRecruitingNCT06651255Not applicable
- A Study of Bleeding and Treatment in Participants With Von Willebrand DiseaseRecruitingNCT06610201
- A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWDRecruitingNCT06205095Phase 3
- Post Trial Access Program of TAK-577 for Von Willebrand Disease (VWD)AvailableNCT06173024
- Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders StudyRecruitingNCT05916469
- Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)RecruitingNCT05776069Phase 1/2
- Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French WestRecruitingNCT05773638
- A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)RecruitingNCT05582993Phase 3
- The Severe Von Willebrand Disease (sVWD) Patient RegistryRecruitingNCT05437536
- ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic DisordersRecruitingNCT04398628
- Von Willebrand Factor in Pregnancy (VIP) StudyRecruitingNCT04146376
- Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic DiseasesRecruitingNCT04119908Not applicable
- Development of a Device for Evaluating Primary Hemostasis Under Whole Blood Flow ConditionsRecruitingNCT03773159
- World Bleeding Disorders RegistryRecruitingNCT03327779
- Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of AgeCompletedNCT04953884Phase 3Results posted
- Prevent Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN TrialCompletedNCT04344860Phase 3Results posted
- Bleeding Incidence in VWD Patients Undergoing On-Demand TreatmentCompletedNCT04053699Results posted
- Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWDCompletedNCT04052698Phase 3Results posted
- A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)CompletedNCT03879135Phase 3Results posted
- Gingival Bleeding and Von Willebrand Disease Typ 2 and 3CompletedNCT03078595Results posted
- rVWF IN PROPHYLAXISCompletedNCT02973087Phase 3Results posted
- Minimize Menorrhagia in Women With Von Willebrand DiseaseTerminatedNCT02606045Phase 3Results posted
- Type 3 Von Willebrand International Registries Inhibitor Prospective StudyCompletedNCT02460458Results posted
- Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing SurgeryCompletedNCT02283268Phase 3Results posted
- Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand DiseaseCompletedNCT01602419Results posted
- Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)CompletedNCT01410227Phase 3Results posted
- Efficacy and Safety of IL-11 in DDAVP UnresponsiveCompletedNCT00994929Phase 2Results posted
- Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand PatientsTerminatedNCT00555555Phase 4Results posted
- IL-11 in Women With Von Willebrand Disease and Refractory MenorrhagiaCompletedNCT00524342Phase 2Results posted
- IL-11 in Adults With Von Willebrand Disease Undergoing SurgeryTerminatedNCT00524225Phase 2Results posted
- The Bleeding Assessment Tool (BAT)Active, not recruitingNCT07560007
- T-TAS® wS Method ComparisonCompletedNCT06710262
- A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)CompletedNCT06433778
- The Lived Experience of People With Von Willebrand DiseaseCompletedNCT06064643
- A Survey to Describe the Experience and Unmet Needs of Persons Living With Von Willebrand Disease (VWD) and Their CaregiversCompletedNCT05695560
- A Study on Estimated Risks of Certain Adverse Events in Adults With Von Willebrand Disease (VWD) Treated With VeyvondiCompletedNCT05265078
- Screening for Bleeding Disorders in ChildrenCompletedNCT05214300
- Genetic Background of Patients With Low Von Willebrand Factor LevelsCompletedNCT05116501Not applicable
- Real-life Data of Constitutional Von Willebrand Disease in Western FranceCompletedNCT04887324
- Impact of Von Willebrand Factor and Its Multimers on AngiogenesisCompletedNCT04810702
- To Assess the Pharmacokinetics and Safety and Tolerability of Efanesoctocog Alfa (BIVV001)in Adults With Type 2N and 3 Von Willebrand Disease (VWD)CompletedNCT04770935Phase 1
- BT200 in Hereditary Bleeding DisordersCompletedNCT04677803Phase 2
- Registry of Patients With Von WilLEbrand Disease Treated With Voncento®CompletedNCT04657887
- Prognostic Value of Implementing VCE on Top in Constitutional VWD-patients With GI-bleedingCompletedNCT04466878
- Latin-American Von Willebrand Disease RegistryStatus unknownNCT04279717
- LTA Assessement Using Aggregometer TA-8V (Stago®)CompletedNCT04269603Not applicable
- Effectiveness and Tolerability of Eqwilate in Real-life ConditionsActive, not recruitingNCT04106908
- A Study of Factor Inhibitors in Adult Patients With Hemophilia and Von Willebrand's Disease in Upper EgyptStatus unknownNCT04106323
- Update in VWD Laboratory DiagnosisStatus unknownNCT03896997
- REAL-LIFE DATA OF CONSTITUTIONAL VON WILLEBRAND DISEASE IN WESTERN FRANCE (HOPSCOTcH-WILL)CompletedNCT03875924
- ATHN 9: Severe VWD Natural History StudyCompletedNCT03853486
- Von Willebrand Antigen and Activity as Novel Biomarkers of Hemostasis in Inflammatory Bowel DiseaseStatus unknownNCT03715673
- Clinical Performance Evaluation of T-TAS 01 PL ChipCompletedNCT03621020
- Von Willebrand Factor Concentrate During ECMO SupportStatus unknownNCT03613584Phase 2
- Von Willebrand Disease in the NetherlandsStatus unknownNCT03521583
- Frequency of Hemorrhages Associated With the Functional Anomalies of Willebrand Factor in Emergency PatientsCompletedNCT03070912
- A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)CompletedNCT02932618Phase 3
- Molecular and Clinical Profile of Von Willebrand Disease in SpainCompletedNCT02869074
- Performance Evaluation of Von Willebrand:Collagen-Binding Assays to Diagnose Von Willebrand Factor Deficiency in Patients With Increased Risk of BleedingCompletedNCT02792205
- Study of Voncento® in Subjects With Von Willebrand DiseaseCompletedNCT02552576Phase 4
- Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand DiseaseWithdrawnNCT02472665Phase 4
- Investigating a Von Willebrand Factor (VWF) Functional Screening Assay for Assigning the Phenotypic Variants of Von Willebrand Disease (VWD)CompletedNCT02466789
- A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.CompletedNCT02246881Phase 3
- Global Hemostatic Methods in Hemophilia and Von Willebrand's DiseaseStatus unknownNCT02061033
- Willebrand International Non-interventional Global SurveillanceCompletedNCT01949220
- The Effect of the Nutraceutical "Hemofix" on the Coagulation SystemWithdrawnNCT01651468Not applicable
- Study on Von Willebrand Disease and Hemophilia in Cuenca, EcuadorCompletedNCT01589848
- Evaluation of Menses in Congenital Bleeding DisordersStatus unknownNCT01261936
- Extension Study of Biostate in Subjects With Von Willebrand DiseaseCompletedNCT01224808Phase 3
- Study of Biostate® in Children With Von Willebrand DiseaseCompletedNCT01213446Phase 3
- Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand DiseaseCompletedNCT00941616Phase 2/3
- Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand DiseaseCompletedNCT00816660Phase 1
- Acquired Von Willebrand Syndrome in Severe Aortic StenosisCompletedNCT00805051
- A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)CompletedNCT00701545
- A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of ARC1779 Injection in Patients With Von Willebrand Disease Type 2BWithdrawnNCT00694785Phase 2
- Collection of Blood in Normal Subjects and Subjects With Von Willebrand Disease (VWD)WithdrawnNCT00630448
- The Von Willebrand Disease (VWD) International Prophylaxis StudyCompletedNCT00557908
- National Study of Moderate and Severe Von Willebrand Disease in the NetherlandsCompletedNCT00510042
- Optivate in People With Von Willebrand Disease Undergoing SurgeryTerminatedNCT00404300Phase 3
- A Study With OPTIVATE® in People With Von Willebrand DiseaseTerminatedNCT00387192Phase 3
- Change in Thrombin Generation Potential and Thromboelastography During the Menstrual CycleTerminatedNCT00178542
- Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)CompletedNCT00168090Phase 4
- Phase II Study of IL-11 (Neumega) in Von Willebrand DiseaseCompletedNCT00151125Phase 2
- Treatment and Management of Women With Bleeding DisordersCompletedNCT00111215Not applicable
- Phase I Study of Human Von Willebrand Factor for Von Willebrand's DiseaseCompletedNCT00004667Phase 1